AI Biomed PredictionsALLR – ALLR’s next rerating likely hinges on ovarian enrollment completion ScanScor Admin / April 21, 2026
AI Biomed PredictionsNXTC – ASCO SIM0505 data could reignite tiny-float NXTC shares ScanScor Admin / April 18, 2026
AI Biomed PredictionsKROS – Keros faces make-or-break DMD launch window in Q2 ScanScor Admin / April 16, 2026
AI Biomed PredictionsKRRO – Korro’s next AATD nomination may reignite platform-belief rally ScanScor Admin / April 15, 2026
AI Biomed PredictionsTLPH – Talphera Nears Critical Trial Completion, Stock Poised to Jump ScanScor Admin / April 1, 2026
AI Biomed PredictionsAGEN – Agenus Poised for Breakthrough with Upcoming Clinical Data ScanScor Admin / March 25, 2026
AI Biomed PredictionsCADL – Promising Phase 3 Data Could Propel Candel Therapeutics ScanScor Admin / March 18, 2026
AI Biomed PredictionsCLRB – Cellectar Poised for Breakout with Key EMA Filing ScanScor Admin / March 13, 2026
AI Biomed PredictionsLXRX – Lexicon Gears Up for Breakout with Key FDA Approvals Ahead ScanScor Admin / March 6, 2026
AI Biomed PredictionsDARE – Dare Bioscience Nears Potential FDA Approvals, Promising Upside ScanScor Admin / July 7, 2025
